Williams M C, Hawgood S, Hamilton R L
Department of Anatomy, Cardiovascular Research Institute, University of California, San Francisco.
Am J Respir Cell Mol Biol. 1991 Jul;5(1):41-50. doi: 10.1165/ajrcmb/5.1.41.
Pulmonary surfactant phospholipids may assume several different structures including tubular myelin, unilamellar and multilamellar vesicles, and others. These populations of materials appear to have similar phospholipid compositions but may differ in their association with surfactant proteins SP-A, SP-B, or SP-C. We have used electron microscopy to determine the changes in structure of simple lipid mixtures (phosphatidylglycerol, dipalmitoylphosphatidylcholine) produced by adding one or combinations of the three proteins. Adding SP-A to lipids generated multilamellar structures composed of membranes with fuzzy or particulate surfaces. In contrast, SP-B or SP-C generated discoidal particles and structures that appeared to be sheets of membrane formed by associated particles. Used together, SP-A and SP-B reorganized some of the lipid into tubular myelin, a structure that was not observed in SP-A, SP-C recombinants. These observations confirm the in vitro formation of tubular myelin reported by others and support the possibility that surfactant materials with defined structure can be produced in vitro for analyses of their molecular organizations.
肺表面活性物质磷脂可能呈现几种不同的结构,包括管状髓鞘、单室和多室囊泡等。这些物质群体似乎具有相似的磷脂组成,但它们与表面活性蛋白SP - A、SP - B或SP - C的结合情况可能有所不同。我们利用电子显微镜来确定添加三种蛋白质中的一种或几种组合后,简单脂质混合物(磷脂酰甘油、二棕榈酰磷脂酰胆碱)的结构变化。向脂质中添加SP - A会产生由具有模糊或颗粒状表面的膜组成的多室结构。相比之下,SP - B或SP - C会产生盘状颗粒和似乎是由相关颗粒形成的膜片结构。SP - A和SP - B一起使用时,会将一些脂质重新组织成管状髓鞘,这种结构在SP - A与SP - C的重组体中未观察到。这些观察结果证实了其他人报道的体外形成管状髓鞘的情况,并支持了这样一种可能性,即可以在体外生产具有特定结构的表面活性物质材料,用于分析其分子组织。